VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis
Open Access
- 17 November 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 20 (3), 367-378
- https://doi.org/10.1038/cr.2009.126
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Endothelial Cell-Produced Antiangiogenic Cytokine Vascular Endothelial Growth Inhibitor Induces Dendritic Cell MaturationThe Journal of Immunology, 2007
- The T Cell Costimulator TL1A Is Induced by FcγR Signaling in Human Monocytes and Dendritic CellsThe Journal of Immunology, 2007
- Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for CancerClinical Cancer Research, 2006
- Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel diseaseGut, 2006
- Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patientsAngiogenesis, 2006
- Vascular Endothelial Growth Inhibitor (VEGI), an Endogenous Negative Regulator of AngiogenesisSeminars in Ophthalmology, 2006
- Inhibition of angiogenesis and breast cancer xenograft tumor growth by vegi, a novel cytokine of the tnf superfamilyInternational Journal of Cancer, 1999
- Blood Vessel Formation: What Is Its Molecular Basis?Cell, 1996
- Clinical Applications of Research on AngiogenesisThe New England Journal of Medicine, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995